Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
2020 · Neurology and Therapy · 24 citations
https://doi.org/10.1007/s40120-020-00201-8
J
Jaber Al-Khabouri
Royal Hospital(OM)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
78
Citations
4
h-index
3
i10-index
Jaber Al-Khabouri is an academic researcher from Royal Hospital. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Dementia and Cognitive Impairment Research & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 4, co-authored 14 publications.
Papers by this author
worksSafety and effectiveness of disease-modifying therapies after switching from natalizumab
2024 · Multiple Sclerosis Journal · 3 citations
https://doi.org/10.1177/13524585241261565
Erratum: Cognitive Profiles in Patients with Multi-Infarct Dementia: An Omani Study
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5241679
181. The Real-world Efficacy and Safety of Off-label Rituximab in a Large Cohort of Middle Eastern Multiple Sclerosis Patients
2024 · Multiple Sclerosis and Related Disorders · 0 citations
https://doi.org/10.1016/j.msard.2024.106142
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines
2026 · CNS Drugs · 0 citations
https://doi.org/10.1007/s40263-025-01260-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat